KEY TAKEAWAY: This labor day is a good time to reflect on how pharma CEO’s can effectively lead while pharma is both under attack and facing turbulent times. Continue reading
KEY TAKEAWAY: DTC marketers continue to spend heavily on TV, despite data from Princeton Research Associates for PhRMA only 11% of all adults has asked for an advertised prescription medication and only 38% have talked to a doctor about an advertised medication. Excuse me?
KEY TAKEAWAY: GSK and Novartis have gone to the outside to hire senior digital marketing people with CPG experience. While these moves are long overdue is it enough or is pharma waiting at the airport for their ship to come in? Continue reading
The pharma industry has been good to me and my wife. It has provided a good living and allowed me to grow professionally and personally. Yet, as an Editor for PM360 and working on a consulting team I have been challenged to either remain quiet when I see clients, focusing too much on things that aren’t important to patients versus listening to our audience at a time when a lot of people are going to need good healthcare. Continue reading
Big pharma shows no sign of wanting to change or implementing change to meet the new challenges of a changing healthcare environment. Continue reading
KEY TAKEAWAY: The idea that it’s time to “kill the medical rep” is myopic and just plain stupid. Pharma sales reps do serve a purpose, but in order to make them more effective pharma has to ensure that they add value to HCP’s. Continue reading
KEY TAKEAWAY: Despite the fact that close to 90 percent of providers participating in meaningful use offer their patients online access, only about one-third of patients actually log in to see their data, according to the U.S. Government Accountability Office. Why? Because providers like Atenahealth offer a lousy user experience. Continue reading